| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Magnesium hydrate |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Polyamine methylene resin |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium antacid |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium oxide |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum-based antacid |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Disodium citrate (substance) |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium acetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Antacid adverse reaction |
Causative agent (attribute) |
True |
Antacid (substance) |
Inferred relationship |
Some |
1 |
| Magnesium trisilicate adverse reaction (disorder) |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| Aluminum hydroxide adverse reaction |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Allergy to antacid |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Allergy to magnesium trisilicate |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Allergy to aluminium hydroxide (finding) |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Anti-gastric acid drug overdose |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
1 |
| Aluminum hydroxide overdose |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Accidental aluminium hydroxide overdose |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Intentional aluminum hydroxide overdose |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide overdose of undetermined intent |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium trisilicate overdose |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| Accidental magnesium trisilicate overdose |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| Intentional magnesium trisilicate overdose |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| surdose de trisilicate de magnésium d'intention indéterminée |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| Official/simple antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide [antacid] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminium hydroxide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide oral suspension BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium salts-antacid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Sodium bicarbonate [antacid] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Compound antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Generic antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium/bismuth antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate compound powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Chalk pediatric mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing chalk (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Chalk aromatic powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aromatic chalk + opium mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate 1.25 g chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 1.5 gram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 2.5 gram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate 1.25 g effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 1.25 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium glubionate + calcium lactobionate 1.09g/723mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium compound 400mg effervescent tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium compound 1000mg effervescent tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide [nutritional use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate 420 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium acetate 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum only antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Antacids containing aluminum and magnesium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Branded antacid preps |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Co-magaldrox product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Antacid liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Antacid tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Antacid powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Co-simalcite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium and magnesium product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium combination product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium acetate 667 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium acetate 333.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium-based antacid |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Alginic acid |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| médicament anti-acide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing aluminium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide+belladonna mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide+belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachet sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Simethicone + hydrotalcite 125mg/500mg oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate 1.25 g and colecalciferol 5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate+cholecalciferol 1.25g/11micrograms/sachet granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 1.5 gram and colecalciferol 10 microgram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Kaolin+calcium carbonate 500mg/250mg/5mL junior suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to alexitol sodium |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction caused by magnesium carbonate (disorder) |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to hydrotalcite |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to magaldrate |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to sodium bicarbonate |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to antacids and antigastric secretion drugs NOS |
Causative agent (attribute) |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing magnesium malate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely magnesium malate 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Disodium etidronate 400mg tablet and calcium carbonate 1.25g effervescent tablet pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth subsalicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth subsalicylate and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium carbonate and etidronate disodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Co-simalcite suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminium compound |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Bismuth compound |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Sodium bicarbonate (substance) |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium carbonate (substance) |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium carbonate and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium glubionate and calcium lactobionate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]